Senate Medicaid Reform Bill Could Mean More Whistleblowers At State Level

A provision in the Senate's Medicaid reform bill that encourages states to pass qui tam laws could increase incentives for whistleblowers to file suits against pharmaceutical companies alleging rebate fraud